These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38016490)

  • 21. Non-raft adenylyl cyclase 2 defines a cAMP signaling compartment that selectively regulates IL-6 expression in airway smooth muscle cells: differential regulation of gene expression by AC isoforms.
    Bogard AS; Birg AV; Ostrom RS
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):329-39. PubMed ID: 24363043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation.
    Linder JU
    Cell Mol Life Sci; 2006 Aug; 63(15):1736-51. PubMed ID: 16786220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyanobacteriochrome-based photoswitchable adenylyl cyclases (cPACs) for broad spectrum light regulation of cAMP levels in cells.
    Blain-Hartung M; Rockwell NC; Moreno MV; Martin SS; Gan F; Bryant DA; Lagarias JC
    J Biol Chem; 2018 Jun; 293(22):8473-8483. PubMed ID: 29632072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Filamin A is a phosphorylation target of membrane but not cytosolic adenylyl cyclase activity.
    Sayner SL; Balczon R; Frank DW; Cooper DM; Stevens T
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L117-24. PubMed ID: 21478251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries.
    Jourdan KB; Mason NA; Long L; Philips PG; Wilkins MR; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1359-69. PubMed ID: 11350817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse.
    Strait KA; Stricklett PK; Chapman M; Kohan DE
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F859-67. PubMed ID: 19955190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae.
    Thangavel M; Liu X; Sun SQ; Kaminsky J; Ostrom RS
    Cell Signal; 2009 Feb; 21(2):301-8. PubMed ID: 19007881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time monitoring of cAMP levels in living endothelial cells: thrombin transiently inhibits adenylyl cyclase 6.
    Werthmann RC; von Hayn K; Nikolaev VO; Lohse MJ; Bünemann M
    J Physiol; 2009 Aug; 587(Pt 16):4091-104. PubMed ID: 19546162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes.
    Ostrom RS; Bundey RA; Insel PA
    J Biol Chem; 2004 May; 279(19):19846-53. PubMed ID: 15007069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the Regulatory Properties of Human Adenylyl Cyclase Type 9.
    Baldwin TA; Li Y; Brand CS; Watts VJ; Dessauer CW
    Mol Pharmacol; 2019 Apr; 95(4):349-360. PubMed ID: 30696718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of adenylyl cyclase proteins in the rodent retina.
    Abdel-Majid RM; Tremblay F; Baldridge WH
    Brain Res Mol Brain Res; 2002 May; 101(1-2):62-70. PubMed ID: 12007833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains.
    Ostrom RS; Liu X; Head BP; Gregorian C; Seasholtz TM; Insel PA
    Mol Pharmacol; 2002 Nov; 62(5):983-92. PubMed ID: 12391260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenylyl cyclase signalling complexes - Pharmacological challenges and opportunities.
    Halls ML; Cooper DMF
    Pharmacol Ther; 2017 Apr; 172():171-180. PubMed ID: 28132906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct stimulation of adenylyl cyclase 9 by the fungicide imidazole miconazole.
    Simpson J; Pálvölgyi A; Antoni FA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Apr; 392(4):497-504. PubMed ID: 30607468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of functional domains of adenylyl cyclase using in vivo chimeras.
    Levin LR; Reed RR
    J Biol Chem; 1995 Mar; 270(13):7573-9. PubMed ID: 7706305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial organization of adenylyl cyclase and its impact on dopamine signaling in neurons.
    Ripoll L; Li Y; Dessauer CW; von Zastrow M
    Nat Commun; 2024 Sep; 15(1):8297. PubMed ID: 39333071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.
    Gille A; Lushington GH; Mou TC; Doughty MB; Johnson RA; Seifert R
    J Biol Chem; 2004 May; 279(19):19955-69. PubMed ID: 14981084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate.
    Pierre SC; Häusler J; Birod K; Geisslinger G; Scholich K
    EMBO J; 2004 Aug; 23(15):3031-40. PubMed ID: 15257286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenylyl cyclase 3/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory effect of forskolin in pancreatic cancer cells.
    Quinn SN; Graves SH; Dains-McGahee C; Friedman EM; Hassan H; Witkowski P; Sabbatini ME
    Mol Carcinog; 2017 Apr; 56(4):1344-1360. PubMed ID: 27891679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.